MedTrace Logo

FAPI-PET for Tumor Detection

NCT04571086 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-11-29

No results posted yet for this study

Summary

This is a prospective observational trial investigating correlation with histopathology, positive predictive value, detection rate, reproducibility and impact on clinical management of 68-Ga-FAPI PET/CT or PET/MRI in patients receiving this imaging modality for tumor staging or restaging as part of clinical care.

Conditions

  • Malignant Neoplasm

Sponsors & Collaborators

  • University Hospital, Essen

    lead OTHER

Principal Investigators

  • Wolfgang Fendler, MD · University Hospital, Essen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2026-04-30
Completion
2027-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04571086 on ClinicalTrials.gov